Aytu BioScience, Inc. (AYTU) financial statements (2020 and earlier)

Company profile

Business Address 373 INVERNESS PARKWAY
ENGLEWOOD, CO 80112
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
8/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments51171970
Cash and cash equivalents51171870
Short-term investments    1  
Restricted cash and investments0000   
Receivables721100 
Inventory, net of allowances, customer advances and progress billings211110
Inventory211110 
Prepaid expense     0 
Other current assets1      
Other undisclosed current assets210000 
Total current assets:1815931080
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0001000
Intangible assets, net (including goodwill)3800121
Goodwill15  000 
Intangible assets, net (excluding goodwill)2300121 
Deposits noncurrent assets000000 
Other noncurrent assets181911911  
Other undisclosed noncurrent assets   1190
Total noncurrent assets:5619121214100
TOTAL ASSETS:7435211524180
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12323410
Accounts payable10222  0
Accrued liabilities21010  
Interest and dividends payable      0
Other undisclosed accounts payable and accrued liabilities    41 
Debt3     0
Deferred rent credit  0
Due to related parties    5 0
Business combination, contingent consideration, liability1110  
Deferred revenue and credits   0 
Other undisclosed current liabilities111010(0)
Total current liabilities:165341010
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt18224741 
Deferred revenue and credits 000 
Deferred tax liabilities, net    0 
Business combination, contingent consideration, liability18224741
Derivative instruments and hedges, liabilities000 0  
Other undisclosed noncurrent liabilities23      
Total noncurrent liabilities:41224741 
Total liabilities:57288111430
Stockholders' equity
Stockholders' equity attributable to parent, including:1771341016(0)
Preferred stock00     
Common stock0000000
Common stock, value, subscriptions      0
Additional paid in capital129113937357390
Accumulated deficit(112)(106)(79)(69)(47)(18)(0)
Receivable from shareholders or affiliates for issuance of capital stock     (5) 
Other undisclosed stockholders' equity attributable to parent      (1)
Total stockholders' equity:1771341016(0)
TOTAL LIABILITIES AND EQUITY:7435211524180

Income statement (P&L) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
8/31/2013
Revenues9743300
Revenue, net  100
Cost of revenue(2)(2)(2)(1)(1)(0)(0)
Gross profit:652220(0)
Operating expenses(27)(24)(23)(23)(24)(8)(0)
Other undisclosed operating income (loss)22211(0) 
Operating loss:(19)(17)(20)(20)(22)(8)(0)
Nonoperating income (expense)(6)(10)10(2)(6) (0)
Investment income, nonoperating   (0)  (0)
Other nonoperating income 06    
Interest and debt expense(1)(1)(1)(3)(5) (0)
Loss from continuing operations before equity method investments, income taxes:(25)(28)(11)(25)(34)(8)(0)
Other undisclosed income (loss) from continuing operations before income taxes    5(0) 
Loss from continuing operations before income taxes:(25)(28)(11)(25)(28)(8)(0)
Income tax benefit     0 
Net loss:(25)(28)(11)(25)(28)(8)(0)
Other undisclosed net income attributable to parent1113  0
Net loss available to common stockholders, diluted:(24)(27)(10)(23)(28)(8)(0)

Comprehensive Income ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
8/31/2013
Net loss:(25)(28)(11)(25)(28)(8)(0)
Comprehensive loss, net of tax, attributable to parent:(25)(28)(11)(25)(28)(8)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: